These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17073780)
1. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen. McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780 [TBL] [Abstract][Full Text] [Related]
2. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427 [TBL] [Abstract][Full Text] [Related]
3. Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions. McLean KJ; Warman AJ; Seward HE; Marshall KR; Girvan HM; Cheesman MR; Waterman MR; Munro AW Biochemistry; 2006 Jul; 45(27):8427-43. PubMed ID: 16819841 [TBL] [Abstract][Full Text] [Related]
4. The preponderance of P450s in the Mycobacterium tuberculosis genome. McLean KJ; Clift D; Lewis DG; Sabri M; Balding PR; Sutcliffe MJ; Leys D; Munro AW Trends Microbiol; 2006 May; 14(5):220-8. PubMed ID: 16581251 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode. Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183 [TBL] [Abstract][Full Text] [Related]
6. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197 [TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of Mycobacterium tuberculosis CYP144: common themes and lessons learned in the M. tuberculosis P450 enzyme family. Driscoll MD; McLean KJ; Cheesman MR; Jowitt TA; Howard M; Carroll P; Parish T; Munro AW Biochim Biophys Acta; 2011 Jan; 1814(1):76-87. PubMed ID: 20621636 [TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169 [TBL] [Abstract][Full Text] [Related]
9. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention. McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022 [TBL] [Abstract][Full Text] [Related]
10. Rapid P450 heme iron reduction by laser photoexcitation of Mycobacterium tuberculosis CYP121 and CYP51B1. Analysis of CO complexation reactions and reversibility of the P450/P420 equilibrium. Dunford AJ; McLean KJ; Sabri M; Seward HE; Heyes DJ; Scrutton NS; Munro AW J Biol Chem; 2007 Aug; 282(34):24816-24. PubMed ID: 17553785 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Podust LM; Poulos TL; Waterman MR Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033 [TBL] [Abstract][Full Text] [Related]
12. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems. McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013 [TBL] [Abstract][Full Text] [Related]
17. Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis. Matsuura K; Yoshioka S; Tosha T; Hori H; Ishimori K; Kitagawa T; Morishima I; Kagawa N; Waterman MR J Biol Chem; 2005 Mar; 280(10):9088-96. PubMed ID: 15611056 [TBL] [Abstract][Full Text] [Related]
18. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. McLean KJ; Munro AW Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141 [TBL] [Abstract][Full Text] [Related]
19. Folding requirements are different between sterol 14alpha-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs. Lepesheva GI; Podust LM; Bellamine A; Waterman MR J Biol Chem; 2001 Jul; 276(30):28413-20. PubMed ID: 11373285 [TBL] [Abstract][Full Text] [Related]
20. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Guardiola-Diaz HM; Foster LA; Mushrush D; Vaz AD Biochem Pharmacol; 2001 Jun; 61(12):1463-70. PubMed ID: 11377375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]